Table 5.
Patients with psoriasis without skin cancers vs. patients with psoriasis and NMSC.
| Psoriasis without Skin Cancers |
Psoriasis and NMSC |
p Value | |
|---|---|---|---|
|
Total (N) Female (N) Male (N) |
75 30 45 |
15 6 9 |
|
|
Age mean ± SD |
49.5 ± 17.6 | 71.1 ± 12.7 | <0.0001 * |
| PASI score | 8.0 ± 3.2 | 9.3 ± 2.7 | 0.14 |
| NGAL (ng/mL) | 139.9 ± 39.3 | 182.3 ± 36.6 | <0.001 * |
| MMP-2 (ng/mL) | 55.3 ± 23.4 | 61.4 ± 74.8 | 0.56 |
| MMP-9 (ng/mL) | 342.4 ± 172.2 | 264.0 ± 84.9 | 0.09 |
| CRP (mg/dL) | 0.4 ± 0.4 | 0.6 ± 0.6 | 0.04 * |
| ESR (mm/h) | 14.7 ± 8.8 | 15.6 ± 9.2 | 0.72 |
| 25(OH)-vitamin D (ng/mL) | 26.2 ± 7.3 | 27.4 ± 8.3 | 0.56 |
NGAL = neutrophil gelatinase-associated lipocalin; MMP = metalloproteinase; CRP = C-reactive protein; ESR= erythrocyte sedimentation rate; * = stastistically significant.